These conclusions were also supported by a similar study that concluded that a high C reactive protein–albumin ratio is associated with poor overall survival, disease-free survival, and progression-free survival in colorectal cancer, and that it can be useful as a prognostic marker for colorectal cancer in clinical practice. The gene discussed is ALB; the disease is colorectal cancer.